Healthcare >> CEO Interviews >> July 5, 2004
TERRANCE OWEN is President, Chief Executive Officer and Director of Alda
Pharmaceuticals. Dr. Owen obtained a Bachelor of Science degree (with
honors) in Biology from the University of Victoria in 1968, a Master's
degree in Biology from the University of New Brunswick in 1970, a PhD in
Zoology from the University of British Columbia in 1974 and a Master's
degree in Business Administration from Simon Fraser University, British
Columbia, in 1991. Since July 1998, Dr. Owen has been the President of
Helix Biotech ULC, a private laboratory providing DNA identity testing
services for paternity, immigration and forensic cases. He was the
President and a director of Helix BioPharma Corp. from July 1995 to June
1998 and International Helix Biotechnologies Inc. from October 1993 to
June 1995. He was the President of Helix Biotech Corporation from
September 1987 to October 1993. Dr. Owen founded the Capital Pool
Company, Duft Biotech, which later acquired the assets of ALDA. The
consequent corporate entity was renamed ALDA Pharmaceuticals Corp. Profile
Dr. Owen: The company was started in 1996 by
Dr. Allan Shapiro, who is the founder and inventor of the company and
the
